Status:
COMPLETED
Radiofrequency Ablation for the Treatment of Gastric Dysplasia
Lead Sponsor:
Hospital Sao Joao
Conditions:
Gastric Dysplasia
Neoplasia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The finding of gastric dysplasia not associated with macroscopic lesions (DNAML) or the follow-up of dysplasia after endoscopic resection (DAER) is a challenging dilemma. In the last few years, radiof...
Detailed Description
Gastric cancer is the fourth most common cancer and the second leading cause of cancer related death worldwide. The 10-year survival of patients with this malignancy is 20% due to advanced disease at ...
Eligibility Criteria
Inclusion
- Histological confirmation of gastric dysplasia.
- The lesion is no larger than 5 cm in diameter.
- Age ≥ 18 years.
- Subject is able to tolerate endoscopy and sedation.
- Subject agrees to participate, fully understands content of the informed consent, and signs the informed consent form.
Exclusion
- Prior gastric irradiation or surgery.
- Anti-platelet or anti-thrombotic medication use that can not be stopped for 7 days before and after RFA.
- Gastric ulcers, fistulae, varices and malignancy.
- History of alcohol and/or controlled substance dependency.
- Pregnancy.
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01523912
Start Date
January 1 2011
End Date
May 1 2015
Last Update
February 22 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gastroenterology Department, Hospital de Sao Joao
Porto, Portugal